LaFlore® Live Probiotic Skincare Shelby IsaacsonP: 941.706.4304 C: 727.687.1570 E: This email address is being protected from spambots. You need JavaScript enabled to view it. D: Nov. 8, 2022 FOR IMMEDIATE RELEASE Spa Industry Visionary, Michael G. Tompkins Joins LaFlore® Live Probiotic Skincare as Board Advisor A talented veteran of luxury hospitality, Michael G. Tompkins’ innovative style is a rare combination of insightful executive leadership, authoritative knowledge of the spa and healthcare industries. Making him the ideal board advisor for LaFlore® Live Probiotic Skincare and its parent company, Dakota Biotech whose mission is to create healthy microbiomes. LaFlore has been created to provide an effective skincare to support the health of skin microbiomes. “Michael Tompkins has an intuitive eye for emerging trends and a deep understanding of the global wellness movement,” shared chairman and CEO of Dakota Biotech, Stephen Buckley. “His enthusiasm and support for LaFlore demonstrates the spa industry’s desire to build a bridge between beauty and health. Michael’s insight is invaluable for LaFlore as we shift how professionals treat their clients’ skin.” With a dual focus on best practices in luxury hospitality and emerging trends in guest preferences and lifestyle choices, Tompkins excels at leveraging brand positioning and expansion to capitalize on the rapidly growing trend toward adoption of health and wellness as a lifestyle in luxury and mainstream markets. His leadership skills have been showcased throughout his career including CEO positions with Miraval Resorts, Hilton Head Health, and PALM Health and held executive positions with Canyon Ranch Health Resorts. He’s also Past Chairman of the International Spa Association (ISPA) and the co-author of three books pertaining to health & wellness. When asked what he finds most compelling about his role with LaFlore, Tompkins shared, “I’m honored to be working with LaFlore. The company is committed to a more holistic approach to skincare. For so many years, we pushed for antibacterial everything, we now know better. The power behind topical LIVE probiotics is what this industry needs for long term wellness.” The Next Generation of Probiotic Skincare LaFlore® Live Probiotic Skincare helps skin by boosting the beneficial bacteria with topical LIVE probiotics, not just probiotic extracts, essences, or lysates. Topical LIVE probiotics help the skin microbiome produce the postbiotic metabolites skin needs to mend and thrive naturally. These postbiotics include AHA, PHA, BHA, vitamins like retinol, antimicrobial peptides, amino acids, micronutrients, antioxidants, anti-inflammatory substances, ceramides and more. The ingenuity behind using topical LIVE probiotics instead of lysate only products is that these products work with the individual’s unique skin microbiome to create exactly what it needs rather than making an educated guess, applying products, and hoping the desired results are achieved. As further support, LaFlore® has a patent (US 10,959,950) for encapsulation of LIVE probiotics allowing them to remain dormant for more than two years without the need for refrigeration and are only activated when applied to the skin making them easy to keep in spa treatment rooms. – Continued – About LaFlore® Live Probiotic Skincare: Dakota Biotech dba LaFlore® Live Probiotic Skincare is a Florida-based manufacturer and skincare company. As worldwide leaders in the LIVE probiotic skincare movement, LaFlore® provides a completely fresh approach to the spa and retail skincare business model with a unique position in the market and is poised for explosive growth with the point of difference being grounded in their proprietary, patented technology which goes far beyond single dose probiotics. Unlike other probiotic skincare lines, LaFlore® delivers a spectrum of touch-activated multibiotics. In line with current consumer values, the brand’s formulas are also dermatologist tested and KIND TO BIOME® and PETA vegan certified. Dakota Biotech also takes that focus on safety even further by employing third-party testing to pharmaceutical standards. ### Want to read more? Subscribe to one of our monthly plans to continue reading this article.